Skip to main content


Full Schedule

Full Schedule

  • Thursday, September 28, 2023
  • 7:00 AM – 8:00 AM EEST
    Career Development Workshop: Nuts and bolts of developing a clinical trial
  • 7:00 AM – 8:00 AM EEST
    Meet the Professor: Clonal hematopoiesis in myeloma: implications for therapy
  • 7:00 AM – 8:00 AM EEST
    Meet the Professor: Light chain amyloidosis
  • 7:00 AM – 8:00 AM EEST
    Meet the Professor: Management of bone disease
  • 7:00 AM – 8:00 AM EEST
    Meet the Professor: Managing renal failure in MM
  • 7:00 AM – 8:00 AM EEST
    Meet the Professor: Optimal imaging approaches in MM
  • 7:00 AM – 8:00 AM EEST
    Meet the Professor: Racial disparity: impact and solutions
  • 7:00 AM – 8:00 AM EEST
    Meet the Professor: Understanding the concept of MGRS
  • 8:00 AM – 9:00 AM EEST
    EHA-IMS Symposium
    Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
    General Session
  • 9:00 AM – 10:00 AM EEST
    IMS Awards
  • 10:00 AM – 10:30 AM EEST
    Presidential Gavel Passing Ceremony
  • 10:00 AM – 1:30 PM EEST
    Exhibition Open
  • 10:30 AM – 12:30 PM EEST
    Novel Technology and Insights in MM
    Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Co-Chair: Gareth Morgan, MD, PHD, FRCP, FRCPATH (he/him/his) – NYU Langone Health Perlmutter Cancer Center
    General Session
  • 12:30 PM – 1:30 PM EEST
    Exhibition and Lunch
  • 12:30 PM – 1:30 PM EEST
    Poster Session 2
  • 1:30 PM – 3:00 PM EEST
    Industry Symposium Supported by Janssen: A new frontier? Redirecting treatment strategies in MM
    Chair: Michel Delforge, MD/Phd – University of Leuven, Leuven, Belgium
    Industry Symposium
  • 3:00 PM – 5:00 PM EEST
    Triple Class Refractory Myeloma
    Chair: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
    Co-Chair: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
    General Session
  • 5:00 PM – 5:15 PM EEST
    Coffee Break
  • 5:15 PM – 6:15 PM EEST
    Abstract Session 3: Novel combinations, access and long term outcomes
    Co-Chair: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
    Co-Chair: Eirini Katodritou, MD, PhD (she/her/hers) – Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
    Oral Abstract Session
  • 5:15 PM – 6:15 PM EEST
    Abstract Session 4: Genomics
    Co-Chair: Masood A. Shammas, PhD – Dana Farber Cancer Institute and VA Boston Healthcare System, Boston, MA, USA
    Co-Chair: Mark Bustoros, MD – Meyer Cancer Center, Weill Cornell Medicine, Cornell University
    Oral Abstract Session
  • 7:00 PM – 10:00 PM EEST
    IMS Cultural Celebration